Sign in
Join
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Wednesday, August 26, 2026
Sign in / Join
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Facebook
Instagram
Twitter
Vimeo
Youtube
Automobile
Two Wheelers
Four Wheelers
Commercial-Vehicles
Aviation
Corporate
Search
Tags
Inhibitor
Tag:
Inhibitor
Healthcare
BeOne Medicines' BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
BFN's Desk
-
May 14, 2026
0
Healthcare
Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting
BFN's Desk
-
November 10, 2025
0
Healthcare
Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally...
BFN's Desk
-
October 8, 2024
0
Automobile
Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor
BFN's Desk
-
February 18, 2024
0
Automobile
Remedy Plan Therapeutics to Showcase Novel NAMPT Inhibitor During Oral Presentation at 2023 American Society of Hematology (ASH) Annual Meeting
BFN's Desk
-
December 11, 2023
0
Featured
Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for NextGeneration Selective PARP1 Inhibitor and AntibodyDrug Conjugate
BFN's Desk
-
October 30, 2023
0
Entertainment
ALLORION THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1/2 STUDY OF ARTS-021, A POTENTIAL BEST IN CLASS CDK2 INHIBITOR, FOR ADVANCED OR METASTATIC SOLID...
BFN's Desk
-
October 12, 2023
0
Entertainment
Scorpion Therapeutics and Pierre Fabre Laboratories Announce First Patient Dosed in Phase 1/2 Clinical Trial of STX-721, a Mutant-Selective EGFR Exon 20 Inhibitor for...
BFN's Desk
-
October 10, 2023
0
Most Read
Sanchi Gets a New Identity in Indore, Reinforcing Its 45-Year Legacy of Trust
August 26, 2026
Škoda expands India sedan portfolio with new Slavia, Octavia RS and Superb TDI
August 22, 2026
India Is Building More Hospitals. But Who Will Train the People to Run Them?
August 20, 2026
Apollo Opens on Sunday. Is India’s Hospital War Moving to the Weekend?
August 20, 2026